| Common Name | 18F1, IMC-18F1, LY3012212 |
|---|---|
| Synonyms | FLT, FLT-1, VEGFR-1, VEGFR1 |
| Applications | ELISA, Flow Cyt |
| Recommended Dilutions | ELISA 1:5000-10000, Flow Cyt 1:100 |
| Buffer | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions. |
| Formulation & Reconstitution | Powder |
| Host Species | Homo sapiens |
| IgG type | IgG1 |
| Reactivity | Human |
| Storage | |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized proteins are shipped at ambient temperature. |
| Guarantee | 12 months from date of dispatch |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
Anti-FLT1(icrucumab biosimilar) mAb
Price: 50μg $80.00 ; 100 μg $160.00
Product Data
Images
Figure 1. ELISA plate pre-coated by 2 μg/mL (100 μL/well) Human FLT1 Protein, His Tag (PME100726) can bind Anti-FLT1 Neutralizing antibody (BME100131) in a linear range of 0.92–234.38 ng/mL.
Figure 2. ELISA plate pre-coated by 2 μg/mL (100 μL/well) Human FLT1 Protein, hFc Tag (PME101032) can bind Anti-FLT1 Neutralizing antibody (BME100131) in a linear range of 3.66–234.38 ng/mL.
Figure 3. Flow cytometry analysis with 1 μg/mL Anti-FLT1 (icrucumab biosimilar) mAb (BME100131) on Expi293 cells transfected with Human FLT1 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).